Editorial: Protein Aggregation and Solubility in Microorganisms (Archaea, Bacteria and Unicellular Eukaryotes): Implications and Applications

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2020 Dec 17

PMID 33329506

Authors

Georgios Skretas

Salvador Ventura

Affiliations

Soon will be listed here.

References

Ferrer-Miralles N, Domingo-Espin J, Corchero J, Vazquez E, Villaverde A . Microbial factories for recombinant pharmaceuticals. Microb Cell Fact. 2009; 8:17. PMC: 2669800. DOI: 10.1186/1475-2859-8-17. View

Mazor Y, Van Blarcom T, Mabry R, Iverson B, Georgiou G . Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli. Nat Biotechnol. 2007; 25(5):563-5. DOI: 10.1038/nbt1296. View

Kostelidou K, Matis I, Skretas G . Microbial Genetic Screens for Monitoring Protein Misfolding Associated with Neurodegeneration: Tools for Identifying Disease-Relevant Genes and for Screening Synthetic and Natural Compound Libraries for the Discovery of Potential Therapeutics. Curr Pharm Des. 2018; 24(19):2055-2075. DOI: 10.2174/1381612824666180515143752. View

Wang L, Maji S, Sawaya M, Eisenberg D, Riek R . Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol. 2008; 6(8):e195. PMC: 2494559. DOI: 10.1371/journal.pbio.0060195. View

Makino T, Skretas G, Kang T, Georgiou G . Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodies. Metab Eng. 2010; 13(2):241-51. PMC: 3057344. DOI: 10.1016/j.ymben.2010.11.002. View

de Marco A, Ferrer-Miralles N, Garcia-Fruitos E, Mitraki A, Peternel S, Rinas U . Bacterial inclusion bodies are industrially exploitable amyloids. FEMS Microbiol Rev. 2018; 43(1):53-72. DOI: 10.1093/femsre/fuy038. View

Makino T, Skretas G, Georgiou G . Strain engineering for improved expression of recombinant proteins in bacteria. Microb Cell Fact. 2011; 10:32. PMC: 3120638. DOI: 10.1186/1475-2859-10-32. View

Garcia-Fruitos E, Gonzalez-Montalban N, Morell M, Vera A, Ferraz R, Aris A . Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact. 2005; 4:27. PMC: 1224866. DOI: 10.1186/1475-2859-4-27. View

Chiti F, Dobson C . Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annu Rev Biochem. 2017; 86:27-68. DOI: 10.1146/annurev-biochem-061516-045115. View

10.

Dasari M, Espargaro A, Sabate R, Lopez Del Amo J, Fink U, Grelle G . Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states. Chembiochem. 2011; 12(3):407-23. DOI: 10.1002/cbic.201000602. View

11.

Villar-Pique A, Espargaro A, Sabate R, de Groot N, Ventura S . Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors. Microb Cell Fact. 2012; 11:55. PMC: 3495732. DOI: 10.1186/1475-2859-11-55. View

12.

Delivoria D, Chia S, Habchi J, Perni M, Matis I, Papaevgeniou N . Bacterial production and direct functional screening of expanded molecular libraries for discovering inhibitors of protein aggregation. Sci Adv. 2019; 5(10):eaax5108. PMC: 6795521. DOI: 10.1126/sciadv.aax5108. View

13.

Matis I, Delivoria D, Mavroidi B, Papaevgeniou N, Panoutsou S, Bellou S . An integrated bacterial system for the discovery of chemical rescuers of disease-associated protein misfolding. Nat Biomed Eng. 2019; 1(10):838-852. DOI: 10.1038/s41551-017-0144-3. View

14.

Otzen D, Riek R . Functional Amyloids. Cold Spring Harb Perspect Biol. 2019; 11(12). PMC: 6886451. DOI: 10.1101/cshperspect.a033860. View

15.

Villar-Pique A, Ventura S . Modeling amyloids in bacteria. Microb Cell Fact. 2013; 11:166. PMC: 3539947. DOI: 10.1186/1475-2859-11-166. View